Radiosensitivity and repair kinetics of gamma-irradiated leukocytes from sporadic prostate cancer patients and healthy individuals assessed by alkaline comet assay

Iranian Biomedical Journal

Volumn 14, Issue 3, 2010, Pages 67-75

  Shahidi, Maryam ^a,c   Mozdarani, Hossein ^a   Mueller, Wolfgang Ulrich ^b  

^a TARBIAT MODARES UNIVERSITY   (Iran)

^b UNIVERSITY HOSPITAL ESSEN   (Germany)

^c MAZANDARAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Comet assay; DNA damage; Leukocytes; Prostate cancer; Radiosensitivity

Indexed keywords

COBALT 60;

ADULT; AGED; ARTICLE; CANCER PATIENT; CANCER SUSCEPTIBILITY; CLINICAL ARTICLE; COMET ASSAY; CONTROLLED STUDY; DNA DAMAGE; DNA FRAGMENTATION; DNA REPAIR; DOSE RESPONSE; GAMMA IRRADIATION; HUMAN; IN VITRO STUDY; IRAN; LEUKOCYTE MOTILITY; MALE; MONONUCLEAR CELL; PREDICTION; PROSTATE CANCER; PROSTATECTOMY; RADIATION DOSE; RADIOSENSITIVITY;

ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; COMET ASSAY; DNA DAMAGE; DNA REPAIR; DOSE-RESPONSE RELATIONSHIP, RADIATION; GAMMA RAYS; HEALTH; HUMANS; KINETICS; LEUKOCYTES; MALE; MIDDLE AGED; PROSTATIC NEOPLASMS; RADIATION TOLERANCE;

EID: 78649590315     PISSN: 1028852X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Jemal, A., Tiwari, R.C., Murray, T., Ghafoor, A., Samuels, A. and Ward, E. (2004) Cancer statistics, 2004. CA Cancer J. Clin. 54: 8-29.
2. Lockett, K.L., Snowhite, I.V. and Hu, J.J. (2005) Nucleotide-excision repair and prostate cancer risk. Cancer Lett. 220: 125-135.
3. Ripple, M.O., Henry, W.F., Rago, R.P. and Wilding, G. (1997) Prooxidant-antioxidant shift induced by androgen treatment of human prostate carcinoma cells. J. Natl. Cancer Inst. 89: 40-48.
4. Nelson, W.G., De Marzo, A.M. and Deweese, T.L. (2001) The molecular pathogenesis of prostate cancer: implications for prostate cancer prevention. Urology 57 (4 Suppl 1): 39-45.
5. Goldgar, D.E., Easton, D.F., Cannon-Albright, L.A. and Skolnick, M.H. (1994) Systematic populationbased assessment of cancer risk in first-degree relatives of cancer probands. J. Natl. Cancer Inst. 86: 1600-1608.
6. Valeri, A., Fournier, G., Morin, V., Morin, J.F., Drelon, E., Mangin, P., Teillac, P., Berthon, P. and Cussenot, O. (2000) Early onset and familial predisposition to prostate cancer significantly enhance the probability for breast cancer in first degree relatives. Int. J. Cancer 86: 883-887.
7. Djuzenova, C.S., Muhl, B., Fehn, M., Oppitz, U., Muller, B. and Flentje, M. (2006) Radiosensitivity in breast cancer assessed by the Comet and micronucleus assays. Br. J. Cancer 94: 1194-1203.
8. Lengauer, C., Kinzler, K.W. and Vogelstein, B. (1998) Genetic instabilities in human cancers. Nature 396: 643-649.
9. Thompson, L.H. and Schild, D. (2002) Recombinational DNA repair and human disease. Mutat. Res. 509: 49-78.
10. Mozdarani, H. and Bryant, P.E. (1989) Kinetics of chromatid aberrations in G2 ataxia-telangiectasia cells exposed to X-rays and ara A. Int. J. Radiat. Biol. 55: 71-84.
11. Carney, J.P. (1999) Chromosomal breakage syndromes. Curr. Opin. Immunol. 11: 443-447.
12. Pichierri, P., Franchitto, A. and Palitti, F. (2000) Predisposition to cancer and radiosensitivity. Genet. Mol. Biol. 23: 1101-1105.
13. Mohseni-Meybodi, A., Mozdarani, H. and Mozdarani, S. (2009) DNA damage and repair of leukocytes from Fanconi anaemia patients, carriers and healthy individuals as measured by the alkaline comet assay. Mutagenesis 24: 67-73.
14. Parshad, R., Price, F.M., Bohr, V.A., Cowans, K.H., Zujewski, J.A. and Sanford, K.K. (1996) Deficient DNA repair capacity, a predisposing factor in breast cancer. Br. J. Cancer 74: 1-5.
15. Rothfuss, A., Schutz, P., Bochum, S., Volm, T., Eberhardt, E., Kreienberg, R., Vogel, W. and Speit, G. (2000) Induced micronucleus frequencies in peripheral lymphocytes as a screening test for carriers of a BRCA1 mutation in breast cancer families. Cancer Res. 60: 390-394.
16. Baeyens, A., Thierens, H., Claes, K., Poppe, B., Messiaen, L., De Ridder, L. and Vral, A. (2002) Chromosomal radiosensitivity in breast cancer patients with a known or putative genetic predisposition. Br. J. Cancer 87: 1379-1385.
17. Varga, D., Michel, I., Patino-Garcia, B., Paiss, T., Vogel, W. and Maier, C. (2005) Radiosensitivity detected by the micronucleus test is not generally increased in sporadic prostate cancer patients. Cytogenet. Genome Res. 111: 41-45.
18. Lockett, K.L., Hall, M.C., Clark, P.E., Chuang, S.C., Robinson, B., Lin, H.Y., Su, L.J. and Hu, J.J. (2006) DNA damage levels in prostate cancer cases and controls. Carcinogenesis 27: 1187-1193.
19. Singh, N.P., McCoy, M.T., Tice, R.R. and Schneider, E.L. (1988) A simple technique for quantitation of low levels of DNA damage in individual cells. Exp. Cell Res. 175: 184-191.
20. Schmezer, P., Rajaee-Behbahani, N., Risch, A., Thiel, S., Rittgen, W., Drings, P., Dienemann, H., Kayser, K.W., Schulz, V. and Bartsch, H. (2001) Rapid screening assay for mutagen sensitivity and DNA repair capacity in human peripheral blood lymphocytes. Mutagenesis 16: 25-30.
21. Mayer, C., Popanda, O., Zelezny, O., von Brevern, M.C., Bach, A., Bartsch, H. and Schmezer, P. (2002) DNA repair capacity after gamma-irradiation and expression profiles of DNA repair genes in resting and proliferating human peripheral blood lymphocytes. DNA Repair (Amst) 1: 237-250.
22. Shahidi, M., Mozdarani, H. and Bryant, P.E. (2007) Radiation sensitivity of leukocytes from healthy individuals and breast cancer patients as measured by the alkaline and neutral comet assay. Cancer Lett. 257: 263-273.
23. Djuzenova, C.S., Rothfuss, A., Oppitz, U., Spelt, G., Schindler, D., Hoehn, H. and Flentje, M. (2001) Response to X-irradiation of Fanconi anemia homozygous and heterozygous cells assessed by the single-cell gel electrophoresis (comet) assay. Lab. Invest. 81: 185-192.
24. Alapetite, C., Thirion, P., de la Rochefordière, A., Cosset, J.M. and Moustacchi, E. (1999) Analysis by alkaline comet assay of cancer patients with severe reactions to radiotherapy: defective rejoining of radioinduced DNA strand breaks in lymphocytes of breast cancer patients. Int. J. Cancer 83: 83-90.
25. Blasiak, J., Arabski, M., Krupa, R., Wozniak, K., Rykala, J., Kolacinska, A., Morawiec, Z., Drzewoski, J. and Zadrozny, M. (2004) Basal, oxidative and alkylative DNA damage, DNA repair efficacy and mutagen sensitivity in breast cancer. Mutat. Res. 554: 139-148.
26. Colleu-Durel, S., Guitton, N., Nourgalieva, K., Legue, F., Leveque, J., Danic, B. and Chenal, C. (2004) Alkaline single-cell gel electrophoresis (comet assay): a simple technique to show genomic instability in sporadic breast cancer. Eur. J. Cancer 40: 445-451.
27. Sanchez, P., Penarroja, R., Gallegos, F., Bravo, J.L., Rojas, E. and Benitez-Bribiesca, L. (2004) DNA damage in peripheral lymphocytes of untreated breast cancer patients. Arch. Med. Res. 35: 480-483.
28. Hussien, M.M., McNulty, H., Armstrong, N., Johnston, P.G., Spence, R.A. and Barnett, Y. (2005) Investigation of systemic folate status, impact of alcohol intake and levels of DNA damage in mononuclear cells of breast cancer patients. Br. J. Cancer 92: 1524-1530.
29. Bergqvist, M., Brattström, D., Stålberg, M., Vaghef, H., Brodin, O. and Hellman, B. (1998) Evaluation of radiation induced DNA damage and DNA repair in human lung cancer cell lines with different radiosensitivity using alkaline and neutral single cell gel electrophoresis. Cancer Lett. 133: 9-18.
30. Scott, D., Barber, J.B., Spreadborough, A.R., Burrill, W. and Roberts, S.A. (1999) Increased chromosomal radiosensitivity in breast cancer patients: a comparison of two assays. Int. J. Radiat. Biol. 75: 1-10.
31. Colleu-Durel, S., Guitton, N., Nourgalieva, K., Lévêque, J., Danic, B. and Chenal, C. (2001) Genomic instability and breast cancer. Oncol. Rep. 8: 1001-1005.
32. Nascimento, P.A., da Silva, M.A., Oliveira, E.M., Suzuki, M.F. and Okazaki, K. (2001) Evaluation of radioinduced damage and repair capacity in blood lymphocytes of breast cancer patients. Braz. J. Med. Biol. Res. 34: 165-176.
33. Smith, T.R., Miller, M.S., Lohman, K.K., Case, L.D. and Hu, J.J. (2003) DNA damage and breast cancer risk. Carcinogenesis 24: 883-889.
34. Scott, D. (2004) Chromosomal radiosensitivity and low penetrance predisposition to cancer. Cytogenet. Genome Res. 104: 365-370.
35. Malins, D.C., Polissar, N.L. and Gunselman, S.J. (1997) Models of DNA structure achieve almost perfect discrimination between normal prostate, benign prostatic hyperplasia (BPH), and adenocarcinoma and have a high potential for predicting BPH and prostate cancer. Proc. Natl. Acad. Sci. USA 94: 259-264.
36. Malins, D.C., Johnson, P.M., Wheeler, T.M., Barker, E.A., Polissar, N.L. and Vinson, M.A. (2001) Agerelated radical-induced DNA damage is linked to prostate cancer. Cancer Res. 61: 6025-6028.
37. Malins, D.C., Johnson, P.M., Barker, E.A., Polissar, N.L., Wheeler, T.M. and Anderson, K.M. (2003) Cancer-related changes in prostate DNA as men age and early identification of metastasis in primary prostate tumors. Proc. Natl Acad. Sci. USA 100: 5401-5406.
38. Hu, J.J., Hall, M.C., Grossman, L., Hedayati, M., McCullough, D.L., Lohman. K. and Case, L.D. (2004) Deficient nucleotide excision repair capacity enhances human prostate cancer risk. Cancer Res. 64: 1197-2201.
39. Popanda, O., Marquardt, J.U., Chang-Claude, J. and Schmezer, P. (2009) Genetic variation in normal tissue toxicity induced by ionizing radiation. Mutat. Res. 667: 58-69.
40. Angele, S., Falconer, A., Edwards, S.M., Dork, T., Bremer, M., Moullan, N., Chapot, B., Muir, K., Houlston, R., Norman, A.R., Bullock, S., Hope, Q. et al. (2004) ATM polymorphisms as risk factors for prostate cancer development. Br. J. Cancer 91: 783-787.
41. Tavtigian, S.V., Simard, J., Teng, D.H., Abtin, V., Baumgard, M., Beck, A., Camp, N.J., Carillo, A.R., Chen, Y., Dayananth, P., Desrochers, M., Dumont, M., Farnham, J.M. et al. (2001) A candidate prostate cancer susceptibility gene at chromosome 17p. Nat. Genet. 27: 172-180.
42. Lambert, S., Mason, S.J., Barber, L.J., Hartley, J.A., Pearce, J.A., Carr, A.M. and McHugh, P.J. (2003) Schizosaccharomyces pombe checkpoint response to DNA interstrand cross-links. Mol. Cell Biol. 23: 4728-4737.
43. Cybulski, C., Gorski, B., Debniak, T., Gliniewicz, B., Mierzejewski, M., Masojc, B., Jakubowska, A., Matyjasik, J., Złowocka, E., Sikorski, A., Narod, S.A. and Lubiński, J. (2004) NBS1 is a prostate cancer susceptibility gene. Cancer Res. 64: 1215-1219.
44. Edwards, S.M, Kote-Jarai, Z., Meitz, J., Hamoudi, R., Hope, Q., Osin, P., Jackson, R., Southgate, C., Singh, R., Falconer, A., Dearnaley, D.P., Ardern- Jones, A., Murkin, A. et al. (2003) Two percent of men with early-onset prostate cancer harbor germ line mutations in the BRCA2 gene. Am. J. Hum. Genet. 72: 1-12.
45. Zhang, M., Siedow, M., Saia, G. and Chakravarti, A. (2010) Inhibition of p21-activated kinase 6 (PAK6) increases radiosensitivity of prostate cancer cells. Prostate 70: 807-816.